No guarantees: planned oocyte cryopreservation, not quite an insurance policy
Authors:
Open Access
- 3 August 2024
- journal article
- review article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 310 (4) , 1889-1894
Abstract
Planned oocyte cryopreservation (OC) has the potential to address the burden of the biological clock, giving women and individuals with ovaries more autonomy in choosing when to have children and with whom. In the United States, the annual number of OC cycles has grown significantly, yet many questions remain regarding planned OC. The field is starting to gather data on the clinical practice and social perspectives around planned oocyte cryopreservation, including the optimal age range at which to offer planned OC, what factors are most predictive of a successful outcome, and the optimal number of oocytes and ovarian stimulation cycles to achieve a live birth. There is a clear need for setting realistic expectations about the chance of success with OC; however, most patients have yet to return to thaw their oocytes, and outcomes data are limited. Clinical models have been developed to predict OC success based on surrogate markers such as age, number of oocytes retrieved, and anti-Müllerian hormone level. Patient education should emphasize the age-related decline in fertility, that eggs do not equal embryos, and that more than one cycle may be needed to obtain sufficient oocytes to have a reasonable chance of future success. While planned OC is not quite an insurance policy against future reproductive challenges, it provides the best option to date for expanding the reproductive window and maximizing reproductive options while navigating individual life circumstances in the context of family building.Keywords
Funding Information
- Ferring Pharmaceuticals
This publication has 41 references indexed in Scilit:
- Utilization of Cryopreserved Oocytes in Patients With Poor Ovarian Response After Planned Oocyte CryopreservationJAMA Network Open, 2024
- Impact of employer-covered planned oocyte cryopreservation on decision-making for medical trainingJournal of Assisted Reproduction and Genetics, 2023
- What do female medical students know about planned oocyte cryopreservation and what are their personal attitudes?Journal of Assisted Reproduction and Genetics, 2023
- Decision regret among women considering planned oocyte cryopreservation: a prospective cohort studyJournal of Assisted Reproduction and Genetics, 2023
- Likelihood of achieving a 50%, 60%, or 70% estimated live birth rate threshold with 1 or 2 cycles of planned oocyte cryopreservationJournal of Assisted Reproduction and Genetics, 2020
- The maternal age‐related first trimester risks for trisomy 21, 18 and 13 based on Danish first trimester data from 2005 to 2014Prenatal Diagnosis, 2016
- Baby budgeting: oocyte cryopreservation in women delaying reproduction can reduce cost per live birthFertility and Sterility, 2015
- What do reproductive-age women who undergo oocyte cryopreservation think about the process as a means to preserve fertility?Fertility and Sterility, 2013
- Pregnancy outcome at extremely advanced maternal ageAmerican Journal of Obstetrics and Gynecology, 2010
- Maternal age and the risk of stillbirth throughout pregnancy in the United StatesAmerican Journal of Obstetrics and Gynecology, 2006